Ameritas Investment Partners’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,854
| Closed | -$5.39K | – | 3152 |
|
|
2024
Q1 | $5.39K | Hold |
2,854
| – | – | ﹤0.01% | 2939 |
|
|
2023
Q4 | $7.54K | Hold |
2,854
| – | – | ﹤0.01% | 2910 |
|
|
2023
Q3 | $6.56K | Hold |
2,854
| – | – | ﹤0.01% | 2939 |
|
|
2023
Q2 | $10.4K | Buy |
+2,854
| New | +$10.4K | ﹤0.01% | 2901 |
|
|
2022
Q2 | – | Sell |
-2,450
| Closed | -$12K | – | 3103 |
|
|
2022
Q1 | $12K | Hold |
2,450
| – | – | ﹤0.01% | 2731 |
|
|
2021
Q4 | $28K | Hold |
2,450
| – | – | ﹤0.01% | 2475 |
|
|
2021
Q3 | $36K | Hold |
2,450
| – | – | ﹤0.01% | 2359 |
|
|
2021
Q2 | $29K | Hold |
2,450
| – | – | ﹤0.01% | 2520 |
|
|
2021
Q1 | $30K | Hold |
2,450
| – | – | ﹤0.01% | 2375 |
|
|
2020
Q4 | $31K | Hold |
2,450
| – | – | ﹤0.01% | 2247 |
|
|
2020
Q3 | $37K | Hold |
2,450
| – | – | ﹤0.01% | 2023 |
|
|
2020
Q2 | $60K | Buy |
2,450
+874
| +55% | +$21.4K | ﹤0.01% | 1721 |
|
|
2020
Q1 | $22K | Hold |
1,576
| – | – | ﹤0.01% | 2119 |
|
|
2019
Q4 | $25K | Hold |
1,576
| – | – | ﹤0.01% | 2297 |
|
|
2019
Q3 | $13K | Hold |
1,576
| – | – | ﹤0.01% | 2608 |
|
|
2019
Q2 | $14K | Hold |
1,576
| – | – | ﹤0.01% | 2638 |
|
|
2019
Q1 | $12K | Hold |
1,576
| – | – | ﹤0.01% | 2625 |
|
|
2018
Q4 | $7K | Hold |
1,576
| – | – | ﹤0.01% | 2772 |
|
|
2018
Q3 | $14K | Hold |
1,576
| – | – | ﹤0.01% | 2685 |
|
|
2018
Q2 | $19K | Buy |
1,576
+824
| +110% | +$9.93K | ﹤0.01% | 2535 |
|
|
2018
Q1 | $11K | Buy |
+752
| New | +$11K | ﹤0.01% | 2684 |
|